Biolimus-coated balloon for new coronary artery blockages
Part of Heart & circulation clinical trials.
This study tests a special balloon coated with a medicine (biolimus) to treat newly formed blockages in the heart's arteries. The balloon is used during a procedure to open the artery and may help keep it open longer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have symptoms of heart disease (like chest pain or shortness of breath) or tests show your heart isn't getting enough blood.
- You have one or two new blockages in your heart arteries that are severely narrowed (at least 70% narrowed, or at least 50% narrowed with symptoms or other evidence of reduced blood flow).
- The blockage is in a vessel that is between 2.75 mm and 4.0 mm wide and the blockage is no longer than 25 mm.
- You have not had a heart attack in the last month, don't have severe heart failure, and don't have serious bleeding or clotting problems.
- You are willing to come back for check-ups after the procedure, including at 30 days, 6 months, 9 months, and 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a special balloon coated with medication to treat newly formed blockages in the heart's arteries. The medication may help keep the artery open after the balloon opens it during a standard procedure.
This trial tests a new balloon coated with sirolimus (a drug that helps prevent re-blockage) for treating blocked arteries at branch points (bifurcations) in the heart. If you have a blocked artery at a branch point, this study may offer a way to treat the side branch without placing a stent there.
This trial is comparing sirolimus and paclitaxel drug-coated balloons to treat new blockages or restenosis (re-blockage) in heart arteries. It aims to see which type of balloon works better for opening arteries without leaving a metal stent behind.
This study is testing a special balloon that releases a drug (sirolimus) to treat fatty plaques in heart arteries that are not yet blocking blood flow. The hope is that this treatment can stabilize or even shrink these plaques, reducing future risk of heart attacks. If you have recently had a heart attack and have other non-obstructive plaques, this trial might offer a new approach.
This study compares two kinds of drug-coated balloons used during angioplasty to open narrowed heart arteries in people with acute coronary syndrome. Both balloons slowly release medicine to help keep the artery open, and the trial aims to see if one works better than the other.
This trial is studying a special balloon coated with a drug that helps keep heart arteries open after they are cleared. It might be an option for people with narrowed heart arteries who need a less invasive treatment.
Hear when a new Coronary Arterial Disease (CAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.